🔗 Share this article

Given that America proceeds with unprecedented revisions to its immunization schedules, an unexpected name appears unexpectedly: Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who first made her name by casting doubt on Covid shots throughout the pandemic and has zeroed in on alleged fatalities after Covid vaccination in her recent time at the Food and Drug Administration.

Planned Shifts to Childhood Immunization Schedule

Health officials planned to reveal radical revisions to the childhood vaccine schedule in December, synchronizing the US with the Danish national calendar, according to reports – a major change that would put the US at odds with many the international standard with insufficient data for public health gain. The planned update has been delayed until the new year.

Instead of Vinay Prasad, Høeg is set to speak at the event. She was recently named temporary leader of the FDA’s drug evaluation center, the fifth individual to head the center this year.

A Shift at the Agency

The acting appointment may indicate a closer partnership between the pharmaceutical and vaccine divisions as Dr. Høeg and Dr. Prasad strengthen their influence at the agency – and it points to a renewed priority upon dismantling long-standing immunizations at the FDA.

The new acting director has repeatedly called for discontinuing specific pediatric immunization guidelines in the US so as to align more similar to Denmark, a society with universal health coverage and a citizenry roughly the size of the state of Wisconsin.

In her initial public appearances, she has persisted in emphasizing on immunizations – usually the responsibility of Dr. Prasad, director of the FDA’s vaccine center – as opposed to pharmaceutical oversight.

Concerns Over Expertise

Dr. Høeg has no apparent background in medication creation, oversight or administrative roles, which has been standard for former leaders of the CBER. She has served at the FDA as a senior adviser to the agency head and CBER since March.

“She doesn’t seem to have any of the qualifications” for running the drug-regulation department, said Dr. Jonathan Howard. “She has not conducted a randomized controlled trial. She lacks experience in leading a large organization. She has no expertise in pharmaceutical oversight.”

Previous commissioners of CBER would “be deeply familiar with legal statutes and the science of pharmaceutical innovation”, commented Dr. Janet Woodcock. “Frankly, she has not acquired the sort of resume that former directors who led CBER have had.”

The drug center has an vast range of responsibilities at the agency, she stated.

“Many people just pays attention on the novel medication approvals, but the generic drug division approves numerous generic medications. There is also a biosimilars program, over-the-counter program and so forth, and every single one must be supervised,” Woodcock noted. “The area you overlook, that is the part that I always told people is going to cause problems.”

There is also, a major management element to the job, which oversees over 5,000 staff members. “It’s a huge management job, if you perform it correctly,” the former official concluded.

Response and Disputed Initiatives

Regarding concerns about Dr. Høeg's credentials and whether this selection represents more teamwork among agency officials on immunizations, a spokesperson responded that the “questions are based on flawed presumptions”.

“Her resume aligns with the duties of her role,” the spokesperson said, noting the time Dr. Høeg spent guiding the agency head on “drug safety and approval science, including computerized risk analysis and vaccine surveillance”.

In her interim role, Høeg assumes responsibility for the agency head's new priority voucher program, a contentious expedited therapy clearance system that reportedly worried her predecessors. “How are these therapies being chosen for this voucher program? Who makes the choices?” Dr. Howard asked. “There’s a lot of lack of transparency happening at the regulatory body right now.”

Overall, he remarked, “the Food and Drug Administration appears to be shifting towards laxer oversight of most medications, with the exception of vaccines.”

Established History on Vaccines

With immunizations, Høeg has a more documented, if problematic, history, some experts observe. She released a study using non-validated public submissions to estimate the frequency of heart inflammation following Covid immunization. She counseled the state of Florida chief medical officer Joseph Ladapo, who allegedly have altered data to suggest Covid vaccinations are pose a greater threat than they are.

Included in her “desired changes” for the new government featured altering guidelines for recently developed shots and ending “optional” immunizations, she stated after the election on a audio program. At the agency, Dr. Høeg has according to sources proposed preventing teenage boys from obtaining Covid vaccinations.

“She is an thorough true believer who starts off with her beliefs and works backwards to retrofit the science in a highly deceptive, dishonest fashion,” Howard argued.

Taking Control and a “Campaign of Retribution”

Dr. Høeg aligned with other dissenters, {like|